These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

140 related items for PubMed ID: 2660507

  • 21. [Measurements of prostatic acid phosphatase and prostate specific antigen by fully automated enzyme immunoassay system--its analytical and clinical evaluation].
    Matui A, Yamada T, Sugita O, Yakata M.
    Rinsho Byori; 1990 Jun; 38(6):693-8. PubMed ID: 1696328
    [Abstract] [Full Text] [Related]

  • 22. [Relationship between reactivation and tumor markers in prostatic cancer].
    Fuse H, Umeda K, Kazama T, Sakamoto M, Sakai T, Fujishiro Y, Mizuno I, Katayama T.
    Hinyokika Kiyo; 1991 Jan; 37(1):39-43. PubMed ID: 1707217
    [Abstract] [Full Text] [Related]

  • 23. [The significance of prostatic serum acid phosphatase as a tumor marker in prostatic cancer].
    Hamami G.
    Hinyokika Kiyo; 1983 Oct; 29(10):1231-45. PubMed ID: 6085711
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. [Changes in tumor markers following cryosurgery of prostate carcinoma].
    Higaki Y, Imamura K.
    Hinyokika Kiyo; 1989 Feb; 35(2):265-70. PubMed ID: 2472049
    [Abstract] [Full Text] [Related]

  • 26. [Benign prostatic hypertrophy with high levels of gamma-seminoprotein (gamma-Sm), prostate specific antigen: report of two cases].
    Asakawa M, Yasumoto R, Kamizuru M, Maekawa M.
    Hinyokika Kiyo; 1988 Dec; 34(12):2189-91. PubMed ID: 2467544
    [Abstract] [Full Text] [Related]

  • 27. [Studies on prostate specific antigen, gamma-seminoprotein (gamma-Sm) as a tumor marker of prostatic cancer].
    Kamachi S, Sakurabayashi I, Kawai T.
    Rinsho Byori; 1984 Jul; 32(7):781-5. PubMed ID: 6389940
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. [Clinical evaluation of serum basic fetoprotein for prostatic cancer--comparative study with PAP, gamma-Sm and PSA].
    Gotoh A, Mizuno Y, Takenaka A, Gohji K, Ogawa T, Arakawa S, Kamidono S, Harada K, Nagata H, Hirooka K.
    Nihon Hinyokika Gakkai Zasshi; 1991 Mar; 82(3):467-72. PubMed ID: 1712873
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. [Evaluation of a monoclonal antibody-based enzyme immunoassay (IQ(Bio) PAP-AELIA kit) for prostatic acid phosphatase].
    Koshida K, Naito K, Hisazumi H.
    Hinyokika Kiyo; 1987 Oct; 33(10):1703-7. PubMed ID: 3328502
    [Abstract] [Full Text] [Related]

  • 34. Clinical evaluation of gamma-seminoprotein in prostate cancer.
    Kuriyama M, Takeuchi T, Shinoda I, Okano M, Nishiura T.
    Prostate; 1986 Oct; 8(3):301-11. PubMed ID: 2422639
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Multiple marker evaluation in prostatic cancer using prostatic specific antigen, gamma-seminoprotein and prostatic acid phosphatase.
    Arai Y, Yoshiki T, Okada K, Yoshida O.
    Urol Int; 1989 Oct; 44(3):135-40. PubMed ID: 2473564
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.